Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I.

Radiology. 2009 Mar;250(3):793-802. doi: 10.1148/radiol.2503080995.

PMID:
19244046
2.

Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.

Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H.

Radiology. 2010 Oct;257(1):135-43. doi: 10.1148/radiol.10092396. Epub 2010 Aug 16.

PMID:
20713607
3.

Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.

Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS.

AJR Am J Roentgenol. 2017 Apr;208(4):812-819. doi: 10.2214/AJR.16.17152. Epub 2017 Jan 26.

PMID:
28125273
4.

Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.

Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS.

Radiology. 2013 May;267(2):444-53. doi: 10.1148/radiol.13112617. Epub 2013 Feb 4.

PMID:
23382290
5.

Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes.

Vargas HA, Chaim J, Lefkowitz RA, Lakhman Y, Zheng J, Moskowitz CS, Sohn MJ, Schwartz LH, Russo P, Akin O.

Radiology. 2012 Sep;264(3):779-88. doi: 10.1148/radiol.12110746. Epub 2012 Jul 24.

PMID:
22829683
6.

[MR imaging features of different renal cell carcinoma subtypes].

Wu B, Peng WJ, Gu YJ, Yang TX, Jiang ZX, Zhang HL, Dai B, Ye DW, Kong YY, Du X.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):825-30. Chinese.

PMID:
19173827
7.

Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging.

Kim JH, Bae JH, Lee KW, Kim ME, Park SJ, Park JY.

Urology. 2012 Oct;80(4):872-6. doi: 10.1016/j.urology.2012.06.001. Epub 2012 Jul 31.

PMID:
22854134
8.

Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.

Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A.

Radiology. 2012 Apr;263(1):160-8. doi: 10.1148/radiol.12111205. Epub 2012 Feb 17.

PMID:
22344404
9.

Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.

Verma SK, Mitchell DG, Yang R, Roth CG, O'Kane P, Verma M, Parker L.

Radiology. 2010 May;255(2):501-7. doi: 10.1148/radiol.09091109. Epub 2010 Feb 16.

PMID:
20160001
10.

Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.

Oliva MR, Glickman JN, Zou KH, Teo SY, Mortelé KJ, Rocha MS, Silverman SG.

AJR Am J Roentgenol. 2009 Jun;192(6):1524-30. doi: 10.2214/AJR.08.1727.

PMID:
19457814
11.

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.

Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM.

Radiology. 2009 May;251(2):398-407. doi: 10.1148/radiol.2512080880. Epub 2009 Mar 10.

PMID:
19276322
12.

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.

Cornelis F, Tricaud E, Lasserre AS, Petitpierre F, Bernhard JC, Le Bras Y, Yacoub M, Bouzgarrou M, Ravaud A, Grenier N.

Eur Radiol. 2014 May;24(5):1068-80. doi: 10.1007/s00330-014-3107-z. Epub 2014 Feb 21.

PMID:
24557052
13.

Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound.

Lu Q, Huang BJ, Xue LY, Fan PL, Wang WP.

AJR Am J Roentgenol. 2015 Sep;205(3):W335-42. doi: 10.2214/AJR.14.14204.

PMID:
26295670
14.

Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?

Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I.

Radiology. 2012 Nov;265(2):468-77. doi: 10.1148/radiol.12112087. Epub 2012 Sep 25.

15.

T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.

Kim S, Jain M, Harris AB, Lee VS, Babb JS, Sigmund EE, Rueff LE, Taouli B.

Radiology. 2009 Jun;251(3):796-807. doi: 10.1148/radiol.2513080724. Epub 2009 Apr 20.

PMID:
19380690
16.

Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.

Choi YA, Kim CK, Park SY, Cho SW, Park BK.

AJR Am J Roentgenol. 2014 Jul;203(1):W78-84. doi: 10.2214/AJR.13.11551.

PMID:
24951231
17.

Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.

Chandarana H, Rosenkrantz AB, Mussi TC, Kim S, Ahmad AA, Raj SD, McMenamy J, Melamed J, Babb JS, Kiefer B, Kiraly AP.

Radiology. 2012 Dec;265(3):790-8. doi: 10.1148/radiol.12111281.

PMID:
23175544
18.

Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.

Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A, Iyer VK, Das P.

Acta Radiol. 2012 Apr 1;53(3):349-58. doi: 10.1258/ar.2011.110415.

PMID:
22496427
19.

Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.

Cornelis F, Lasserre AS, Tourdias T, Deminière C, Ferrière JM, Le Bras Y, Grenier N.

AJR Am J Roentgenol. 2013 Apr;200(4):830-8. doi: 10.2214/AJR.12.9122.

PMID:
23521457
20.

Magnetic resonance imaging as a biomarker in renal cell carcinoma.

Pedrosa I, Alsop DC, Rofsky NM.

Cancer. 2009 May 15;115(10 Suppl):2334-45. doi: 10.1002/cncr.24237. Review.

Supplemental Content

Support Center